Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2322-2335
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Variable | Group I (n = 105) | Group II (n = 175) | Group III (n = 139) | Group IV (n = 86) | F/χ2 | P |
Clinical feature | ||||||
Haematemesis | 6 (5.7) | 12 (6.9) | 16 (11.5) | 16 (18.6) | 11.588 | 0.009 |
Edema | 2 (1.9) | 12 (6.9) | 20 (14.4) | 33 (38.4) | 65.284 | < 0.001 |
SBP | 1 (1.0) | 4 (2.3) | 11 (7.9) | 13 (15.1) | 23.486 | < 0.001 |
Hyponatremia | 3 (2.9) | 21 (12.0) | 31 (22.3) | 31 (36.0) | 42.806 | < 0.001 |
Hepatic encephalopathy | 5 (4.8) | 10 (5.7) | 14 (10.1) | 19 (22.1) | 21.565 | < 0.001 |
Refractory ascites | 2 (1.9) | 4 (2.3) | 15 (10.8) | 21 (24.4) | 44.367 | < 0.001 |
Jaundice | 12 (11.4) | 13 (7.4) | 15 (10.8) | 20 (23.3) | 14.120 | 0.003 |
MELD score | 8.74 ± 1.54 | 8.64 ± 1.57 | 17.04 ± 1.96a,b | 25.19 ± 2.15a,b,c | 2081.425 | < 0.001 |
Laboratory index | ||||||
RDW (%) | 12.54 ± 0.85 | 13.29 ± 1.19a | 14.3 ± 1.96a,b | 16.25 ± 2.13a,b,c | 101.958 | < 0.001 |
TBIL (μmol/L) | 12.3 (10.9, 13.45) | 11.5 (9.8, 14.5) | 12.8 (10.7, 17.5)b | 16.3 (13.18,24.95)a,b,c | 57.344 | < 0.001 |
ALB (g/L) | 45.91 ± 3.83 | 44.92 ± 5.19a | 37.85 ± 4.71a,b | 33.50 ± 5.65a,b,c | 159.072 | < 0.001 |
ALT (IU/L) | 24 (18, 32) | 27 (21, 34)a | 32 (23, 37)a,b | 35 (26, 75)a,b,c | 40.591 | < 0.001 |
AST (IU/L) | 26 (19.5, 33) | 28 (21, 35) | 30 (22, 36)a | 34 (25, 62)a,b | 25.257 | < 0.001 |
γ-GT (IU/L) | 32 (20, 44) | 30 (22, 41) | 35 (26, 43) | 37 (26, 47)a,b | 14.96 | 0.002 |
ALP (IU/L) | 65 (52, 84) | 74 (53, 88) | 69 (54, 87) | 69 (58, 84) | 3.535 | 0.316 |
WBC count (× 109/L) | 5.64 ± 1.51 | 5.36 ± 1.40 | 5.76 ± 1.16b | 6.10 ± 1.55a,b | 5.695 | 0.001 |
Hemoglobin (g/L) | 122.86 ± 15.53 | 121.10 ± 15.30 | 107.92 ± 16.33a,b | 99.28 ± 18.15a,b,c | 52.186 | < 0.001 |
Platelet count (× 109/L) | 190.15 ± 62.47 | 174.98 ± 41.71a | 101.09 ± 27.46a,b | 90.38 ± 32.33a,b | 165.715 | < 0.001 |
INR | 0.91 (0.59, 1.27) | 1.21 (0.61, 1.80)a | 1.58 (0.86, 2.41)a,b | 1.37 (1.17, 2.22)a,b | 57.797 | < 0.001 |
NT-proBNP (pg/mL) | 72 (61, 84) | 76 (61, 98) | 354 (127, 653)a,b | 647 (364, 1430)a,b,c | 242.974 | < 0.001 |
eGFR (ml/min/1.73 m2) | 62.35 ± 11.09 | 60.87 ± 13.52 | 59.07 ± 15.94 | 43.31 ± 11.39a,b,c | 40.691 | < 0.001 |
Drug information | ||||||
Diuretic | 3 (2.9) | 7 (4) | 20 (14.4) | 32 (37.2) | 69.996 | < 0.001 |
Spirolactone | 3 (2.9) | 7 (4) | 17 (12.2) | 26 (30.2) | 50.491 | < 0.001 |
ACEI/ARB | 7 (6.7) | 23 (13.1) | 22 (15.8) | 23 (26.7) | 15.690 | 0.001 |
β-blocker | 6 (5.7) | 13 (7.4) | 23 (16.5) | 22 (25.6) | 23.776 | < 0.001 |
- Citation: Chen YL, Zhao ZW, Li SM, Guo YZ. Value of red blood cell distribution width in prediction of diastolic dysfunction in cirrhotic cardiomyopathy. World J Gastroenterol 2023; 29(15): 2322-2335
- URL: https://www.wjgnet.com/1007-9327/full/v29/i15/2322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i15.2322